News for Homology Medicines Stock (FIXX)

HOMOLOGY ALERT: Bragar Eagel & Squire, P.C. is Investigating Homology Medicines, Inc. on Behalf of Homology Stockholders and Encourages Investors to Contact the Firm

Business Wire • 04/02/22

FIXX ALERT: Investors with Substantial Losses Have Opportunity to Lead Homology Medicines, Inc. Class Action Lawsuit

Business Wire • 04/01/22

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FIXX

Newsfile Corp • 04/01/22

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Homology Medicines (FIXX) Investors to Securities Fraud Class Action, Encourages Investors with Significant Losses to Contact the Firm

Newsfile Corp • 03/31/22

Bronstein, Gewirtz & Grossman, LLC Notifies Homology Medicines, Inc. (FIXX) Shareholders of Class Action and Encourages Investors to Contact the Firm

Business Wire • 03/31/22

ALERT: Homology Medicines, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FIXX

PRNewsWire • 03/31/22

FIXX Shareholder Class Action: Robbins LLP Reminds Investors of Class Action Against Homology Medicines, Inc. (FIXX)

Business Wire • 03/30/22

EQUITY NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FIXX

Business Wire • 03/29/22

FIXX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Investors in Homology Medicines (FIXX) with Significant Losses to Contact Firm, Securities Fraud Class Action Filed

PRNewsWire • 03/29/22

SHAREHOLDER ALERT: Robbins LLP Informs Shareholders of Class Action Against Homology Medicines, Inc. (FIXX)

Business Wire • 03/28/22

HOMOLOGY MEDICINES, INC. (NASDAQ: FIXX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Homology Medicines, Inc. (NASDAQ: FIXX)

PRNewsWire • 03/28/22

Pomerantz Law Firm Announces the Filing of a Class Action Against Homology Medicines, Inc., and Certain Officers - FIXX

PRNewsWire • 03/26/22

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Homology Medicines, Inc. - FIXX

Newsfile Corp • 03/24/22

Homology Medicines Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights

GlobeNewsWire • 03/23/22

Oxford Biomedica broadens its viral vector capabilities with the launch of Oxford Biomedica Solutions, a full scope AAV business in Boston, following closing of its deal with Homology

GlobeNewsWire • 03/11/22

Homology Medicines Announces Closing of Deal Leveraging its Internal Process Development and CMC Capabilities Through Newly Formed AAV Manufacturing Innovation Business with Oxford Biomedica

GlobeNewsWire • 03/10/22

Here's Why Homology Medicines (FIXX) Looks Ripe for Bottom Fishing

Zacks Investment Research • 03/08/22

Why Homology Medicines (FIXX) Might Surprise This Earnings Season

Zacks Investment Research • 03/07/22

Homology Medicines (FIXX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Zacks Investment Research • 03/03/22

Homology Medicines to Participate in Upcoming Investor Conferences

GlobeNewsWire • 03/03/22

Here's Why Homology Medicines (FIXX) is Poised for a Turnaround After Losing 25.1% in 4 Weeks

Zacks Investment Research • 02/23/22

Homology Medicines Stock Plunges After FDA Clinical Hold On Gene Therapy Trial

Benzinga • 02/22/22

Homology Medicines Provides an Update on pheNIX Gene Therapy Trial for Adults with PKU

GlobeNewsWire • 02/18/22

Homology Medicines Announces Presentations on HMI-203 Investigational Gene Therapy for Hunter Syndrome and Broad Applicability of AAVHSC Platform for Lysosomal Storage Disorders at the 18th Annual WORLDSymposium™ Meeting

GlobeNewsWire • 02/10/22

Is Homology Medicines (FIXX) Stock Outpacing Its Medical Peers This Year?

Zacks Investment Research • 02/02/22